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Women derive less benefit from elective
endovascular aneurysm repair than men
Manish Mehta, MD, MPH, W. John Byrne, MCh, FRCSI(Gen), Handel Robinson, MD,
Sean P. Roddy, MD, Philip S. K. Paty, MD, Paul B. Kreienberg, MD, Paul Feustel, PhD, and
R. Clement Darling III, MD, Albany, NY
Background: Women have a lower chance of surviving elective open abdominal aortic repair. The reasons for this are not
clear. Endovascular repair has clearly reduced early and midterm morbidity and mortality for patients with large
abdominal aortic aneurysms (AAAs). However, most patients are male. It is unclear whether there has been any reduction
in elective morbidity for females or what the extent of that reduction has been. We prospectively analyzed outcomes for
elective endovascular aneurysm repair (EVAR) in women at our center and compared results with those for elective open
surgery and emergent open and endovascular repair.
Methods: All patients undergoing elective and emergency AAA from 2002 to 2009 were prospectively entered into a
database. Demographic details, including gender, were tabulated. Outcome measures were operative blood loss, incidence
of type 1 endoleaks, length of in-hospital stay, postoperative complications, 30-day all-cause mortality, and secondary
interventions during the follow-up period. Statistical analysis was performed using Fischer exact test and Student t test.
A multivariate analysis was also performed.
Results: From 2002 to 2009, there were 2631 abdominal aortic aneurysms (AAA) open and endovascular repairs
performed in our center (1698 endovascular aneurysm repairs [EVARs], 933 “open”). Males comprised 1995 (76%) of
patients; females 636 (24%). There were 1592 elective EVARs (1248 male, 344 female) and 106 emergency EVARs (73
male, 33 female). Elective open repair was performed in 788 patients (579 male, 209 female) and emergency open repair
in 149 (73 male, 76 female). For women, elective EVAR resulted in significantly greater mortality rates than men (3.2%
vs 0.96%, P < .005). There was a greater incidence of intraoperative aortic neck or iliac artery rupture (4.1% vs 1.2% P 
.002) and use of Palmaz stents for type 1 endoleaks (16.1% vs 8%, P  .0009). Mean blood loss was greater in females
(327 mL vs 275 mL, P  .038). Perioperative complications were also more frequent in women: leg ischemia (3.5% vs
0.6%, P .003) and colon ischemia requiring colectomy (0.9% vs 0.2%, P .009). Mean hospital stay was also longer (3.7
days vs 2.2 days, P .0001). In contrast, there were no gender differences for any of these outcome measures for elective
open repair or emergency open surgery or EVAR. There was no significant difference in death rates between EVAR
and open repair in women (3.2% vs 5.7%). In males, the 30-day mortality was 0.96% for elective EVAR and 4.7% for
elective open surgery. Following logistic regression, female gender remains a significant risk even when the effects of
aneurysm size and age are considered (odds ratio 3.4, P < .01).
Conclusions: Mortality for females undergoing elective EVAR is significantly greater than for males. It is also more
hazardous. Colon ischemia, native arterial rupture, and type 1 endoleaks are more frequent. Elective endovascular
aneurysm repair benefits men more than women. (J Vasc Surg 2012;55:906-13.)
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sVascular disease affects men and women differently.
Women have poorer outcomes following carotid endarter-
ectomy, leg bypass operations, and abdominal aortic aneu-
rysm (AAA) repair.1–3 Large abdominal aortic aneurysms
(5.0 cm in diameter) are found in 0.45% of the male
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906opulation aged 50 to 79 years.4 While there is a lower
revalence of AAAs in women, following rupture, their
urvival rate is lower,5 and those who live have higher rates
f postoperative complications.3 In the pre-endovascular
ra, although operative mortality rates for all patients were
igher, women undergoing elective open repair had sur-
ival rates equivalent to those for men.6
Over the past two decades, endovascular aneurysm
epair (EVAR) has been shown to decrease the short- and
idterm morbidity and mortality associated with AAA
epair.7,8 This benefit has not been equally distributed
etween the genders. Women tend to have aortoiliac mor-
hology that is less suitable for EVAR. Their procedures are
ore likely to be converted to open surgery repair (OSR) or
bandoned.9 Many of the early studies looking at these
ender differences in AAA repair were hampered by small
atient numbers.10 In part, this is because women usually
omprise only one-sixth to one-fifth of patients in most
eries. In our center, we are fortunate to have a large patient
opulation. Consequently, we also treat large numbers of
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Volume 55, Number 4 Mehta et al 907female AAA patients. Our management algorithms are
standardized across our group and the operating surgeons
have remained largely the same over this period. This allows
us to quantify any differences in outcome between males
and females undergoing AAA repair. It also may allow us to
define those differences and understand why they occur.
The aim of this article is to focus on comparative outcomes
for men and women undergoing elective EVAR.
METHODS
This was a retrospective Institutional Review Board
(IRB)-approved analysis of a prospectively maintained da-
tabase. Chart review was also performed. Between 2002
and 2009, 2631 consecutive patients with AAA underwent
OSR or endovascular repair of their AAAs in our center. All
EVARs were performed using US Food and Drug Admin-
istration (FDA)-approved and commercially available stent
grafts. The stents used were Excluder (W. L. Gore and
Associates, Flagstaff, Ariz), AneuRx (Medtronic, Santa
Rosa, Calif), Zenith (Cook, Bloomington, Ind), Talent
(Medtronic, Santa Rosa, Calif), and Powerlink (Endologix,
Irvine, Calif). All EVARs were performed by surgical expo-
sure of the common femoral or distal external iliac arteries.
There were no total percutaneous endovascular procedures
in this group of patients. Open surgical repair was accom-
plished in all cases by a left retroperitoneal approach. This
was used for both elective and ruptured AAA. Patient
selection for EVAR or open surgical repair was dependent
on the surgeon’s discretion and was generally based on the
morphologic inclusion criteria for a particular stent graft,
and the patients’ preference for the type of repair. Postop-
erative follow-up included clinical examination, pulse vol-
ume recording, duplex ultrasound imaging, and computed
tomography angiography (CTA)/magnetic resonance an-
giography (MRA) at 1, 6, and 12 months, and yearly
thereafter. The need for secondary procedures was defined
on the basis of intraoperative or postoperative complica-
tions. The data were prospectively tabulated using our
vascular database. Outcomemeasures were operative blood
loss, incidence of type 1 endoleaks, length of in-hospital
stay, postoperative complications, 30-day all-cause mortal-
ity, and secondary interventions during the follow-up
period. Secondary and tertiary interventions were also doc-
umented. General postoperative complications were classi-
fied as cardiac (specifically postoperative myocardial isch-
emia or congestive heart failure), pulmonary (pneumonia),
or renal (worsening of renal function requiring intensive
medical treatment or renal replacement therapy). More
specific complications such as aortic neck rupture and colon
ischemia were described separately. Dichotomous outcome
variables (eg, presence of endoleaks, complications, mortal-
ity) were analyzed using two-by-two tables and, because of
the usually low numbers of complications, Fisher exact test
(two-tailed) was used to test for statistical significance. For
continuous variables, groups were compared using a t test
with P value .05 considered to be statistically significant.
The effect of potential predictors on 30-day mortality was
assessed by logistic regression with each variable first con- sidered separately. The odds ratio is the odds of 30-day
ortality in the presence of the risk factor relative in the
bsence of the risk factor for dichotomous factors. For
ontinuous variables the odds ratio represents the increase
or decrease if 1) in the odds of death for each unit
ncrease in the variable. The effect of all factors considered
ogether was assessed bymultiple logistic regression with all
ain effects as candidates. Stepwise regression was used to
arrow the number of factors to only those with statistically
ignificant effects when considered in the presence of other
actors.
ESULTS
From 2002 to 2009, 2631 consecutive patients under-
ent either EVAR (n  1698, 64.5%) or open surgical
epair (n 933, 35.5%). Of these, 90.5% (n 2380) were
lective. Only 9.5% (n 251) were deemed emergent. The
ean follow-up was 26 months. Patients were categorized
s (1) elective EVAR (60.5%, n  1592), (2) emergent
VAR (4%, n  106), (3) elective open surgical repair
29.9%, n  788), and (4) emergent open surgical repair
5.5%, n  145) (Fig).
lective EVAR: Male vs female (Table I)
From 2002 to 2009, 1592 patients underwent elective
VAR. Of these, there were 1248 men (78%) and 344
omen (22%).
Risk factors. Women were significantly older than
en (mean age: women, 75.0 vs men, 73.3; P .001).
hey also had a significantly higher incidence of chronic
bstructive pulmonary disease (COPD) (women, 23.8% vs
en, 16.9%; P .005). However, there were no significant
ender differences in other risk factors, including coronary
rtery disease (CAD) (women, 64% vs men, 65%; P  ns),
ssential hypertension (women, 83% vs men, 80%; P ns),
hronic renal insufficiency (women, 12.2% vs men, 9.2%;
 ns), or mean AAA size (women, 5.6 cm [range, 4
m-11.5 cm] vs men, 5.6 cm [range, 4 cm-11.5 cm];
 ns).
Intraoperative events. During elective EVAR, women
ad a significantly higher incidence of intraoperative arterial
upture (women, 4.1% vs men, 1.3%; P  .002). Of these
4 cases of native arterial rupture, three were aortic neck
uptures. One of these was converted to open surgery but
ied postoperatively due to multisystem organ failure. Two
ere managed endovascularly by graft extension. One of
hese also died in the postoperative period. The remaining
1 native arterial ruptures were iliac artery ruptures. Of
hese, seven were managed by endovascular means, four
equired open surgery. Of the patients who had iliac rup-
ure, four died in the postoperative period. Mean estimated
lood loss (EBL) was higher (women, 327mL vs men, 275
L; P  .04). Type 1 endoleaks at completion of stenting
ere more frequent in women prompting greater use of
almaz stents (Cordis Corp, Bridgewater, NJ) at the aortic
eck (women, 16.1 vs men, 8.0; P  .001).
Postoperative course. In this cohort, women also had a
ignificantly higher incidence of postoperative complica-
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April 2012908 Mehta et altions, including bleeding requiring reoperation (women,
4.94% vs men, 2.08%; P .01), pulmonary (women, 2.91%
vs men, 1.04%; P  .02). More women developed colon
ischemia requiring colectomy than men (women, 0.87% vs
men, 0.16%; P  .01). Of these patients, one died. Acute
leg ischemia was also more frequent in females (women,
3.49% vs men, 0.64%; P .001). In 10/12 patients, the
reason for acute ischemia was access site thrombosis. In the
remaining two patients, the cause was graft limb occlusion.
All ischemic complications were managed by local groin
exploration and correction of the underlying defect. No
patients required extra-anatomical reconstruction and
there were no deaths or amputations in this group.
Mortality (Fig). Thirty-day mortality was higher in
females (women, 3.2% vs men, 0.96%; P .004) undergo-
ing elective EVAR and they stayed in hospital longer (mean
hospital length of stay for women was 3.68 days compared
with 2.10 days for men P  .001). There were no intraop-
erative deaths. The causes of death (n  11) were aortic
neck rupture (n  2), iliac artery rupture (n  4), colon
ischemia (n  1), and multisystem organ failure (n  4).
The mortality data was compared among all four groups.
Women have a significantly higher incidence of 30-day
mortality than men when undergoing elective EVAR. In all
other circumstances (emergent EVAR, elective open surgi-
cal repair, and emergent open surgical repair for ruptured
AAA), the 30-day mortality rates were not significantly
different by gender.
Comparison of EVAR with open elective AAA sur-
gery in women. When compared with outcomes for OSR,
although women undergoing EVAR had a lower 30-day
mortality, this difference was not statistically significant
(EVAR, 3.2% vs OSR, 5.7%; P  .19). Women lost the
30-day survival advantage that is seen in men that are
treated by EVAR vs OSR. There was a significant difference
in the women’s mean age (EVAR, 75 years vs OSR, 73
30 Day
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Fig. Mortality among all abdominal aortic aneurysm (A
and emergent endovascular aneurysm repair (EVAR).years; P  .004), and their incidence of CAD (EVAR, T4.2% vs OSR, 45.0%; P  .001). Other risk factors were
imilar, including pre-existing renal failure (EVAR, 12.2%
s OSR, 8.6%; P  .21), hypertension (EVAR, 82.6% vs
SR, 76.6%; P  .1), and COPD (23.8% vs 25.36%; P 
68). When compared to the OSR, the women with EVAR
ad significantly less mean EBL (326 mL vs 1157 mL; P
001), postoperative ischemic colitis requiring colectomy
EVAR, 0.87% vs OSR, 4.3%; P  .01). The incidence of
yocardial infarctions (EVAR, 1.74% vs OSR, 4.31%; P 
1), pulmonary complications (EVAR, 2.9% vs OSR,
.22%; P  .08), and lower extremity ischemic complica-
ions (EVAR, 3.5% vs OSR, 1.9%; P  .43) were similar in
oth groups.
Results of multivariate analysis of elective EVAR in
omen. The odds of mortality for women undergoing
lective EVAR were 3.4 times that of men (Table II). The
ffect of all factors considered together was assessed by
ultiple logistic regression with all main effects as candi-
ates. Stepwise regression was used to narrow the number
f factors to only those with statistically significant effects
hen considered in the presence of other factors (Table
II). Despite this, female gender remained a significant risk
ven when the effects of aneurysm size and age are incor-
orated in the model. When considered separately female
ender, age, aneurysm size, and renal disease all were
ignificantly associated with 30-day mortality. When con-
idered together, gender, size, and age all predicted
ortality.
mergent EVAR: Male vs female (Table IV)
Emergent EVAR was performed in 106 (4.0%) pa-
ients. In this group, women (n  33, 31%) and men (n 
3, 69%), were of similar age (women, 74.4 years vs men,
2.5 years; P  ns). Aneurysm size was the same on
resentation (women: mean, 6.4 cm [range, 4 cm-10 cm]
s men: mean, 6.4 cm [range, 3.9 cm-10 cm]; P  ns).
ality
Open AAA
Elective
Emergent
EVAR
Elective
EVAR
Male %
Female %
*0.5771
*0.445
*0.004
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Volume 55, Number 4 Mehta et al 909factors: COPD (women, 15.15% vs men, 23.29%; P ns),
CAD (women, 57.6% vsmen, 65.8%; P ns), hypertension
(women, 84.9% vs men, 87.7%; P  ns), and pre-existing
renal disease (women, 9.09% vs men, 13.7%; P ns).Males
and females had similar rates of intraoperative complica-
tions, including EBL (women, 430 mL vs men, 310 mL;
P  ns), arterial ruptures (women, 0% vs men, 4.11%; P 
ns) and Palmaz stent placements (women, 1.73% vs men,
0.89%; P ns). Thirty-day mortality and the mean hospital
length of stay were similar in both genders. However, men
required significantly more secondary interventions during
follow-up after EVAR (men, 30.12% vs women, 9.09%;
Table I. Elective EVAR males vs females
Mal
n
Total EVAR 1248
Age (years) 73.3
Aneurysm size 5.63 (range
Factors
Coronary artery disease 812
Renal 115
Hypertension 1000
Chronic obstructive pulmonary disease 211
Intraop complications
Estimated blood loss (mL) 275
Arterial rupture 15
Palmaz stent placement 90
Morbidity
Cardiac 18
Pulmonary 13
Bleeding 26
Renal 17
Colon ischemia 2
Distal ischemia 8
Length of stay (days) 2.19
30-day mortality 12
Stent graft occlusion 21
Endoleaks 382
Secondary interventions (EVAR) 230
EVAR, Endovascular aneurysm repair.
Table II. Univariate odds ratio for 30-day mortality in
the EVAR elective group
Variable Odds ratio
95% odds ratio
confidence interval P
Female gender 3.40 1.49-7.78 .01
Age (per year) 1.10 1.04-1.16 .01
Aneurysm size (per cm) 1.47 1.13-1.92 .01
Diabetes mellitus 1.27 0.43-3.77 .67
Hypertension 1.61 0.47-5.45 .45
Coronary artery disease 1.01 0.43-2.41 .97
Smoker 0.68 0.20-2.31 .54
Chronic obstructive
pulmonary disease 1.24 0.45-3.36 .68
Hypercholesterolemia 0.87 0.38-2.00 .74
Renal 3.31 1.29-8.53 .01
EVAR, Endovascular aneurysm repair.
Effect of variable when considered separately on 30-day mortality.P  .03). plective open surgical repair: Male vs female
Table V)
Of the 788 (33.8%) patients that underwent elective
SR, women comprised 23.5% (n  209) and men 65.2%
n  579). Women were significantly older than men
women, 73 years vs men, 70 years; P  .001), and at
resentation, men’s aneurysms were significantly larger
men: mean, 6.19 cm [range, 4 cm-16 cm] vs women:
ean, 5.79 cm [range, 4 cm-11 cm]; P .001). However,
omen had a significantly higher incidence of hypertension
women, 76.6% vs men, 65.2%; P  .027) and COPD
women, 25.4% vs men, 12.6%; P  .001). There were no
ender differences in pre-existing chronic renal insuffi-
iency (men, 7.1% vs women, 8.6%; P  ns) and CAD
men, 43.01% vs women, 44.98%; P  .63). When com-
ared with women, men had a significantly higher mean
BL (men, 1394 mL vs women, 1157 mL; P  .01) but
here were no differences in the mean length of stay and any
Females
P valuetotal n % of total
% 344 100%
75 .0011
cm-11 cm) 5.55 (range, 4 cm-11.5 cm) .1673
.06% 221 64.24% .7987
.21% 42 12.21% .1027
.13% 284 82.56% .3549
.91% 82 23.84% .0046
326.5 .0381
.20% 14 4.07% .0020
.01% 56 16.14% .0009
.44% 6 1.74% .4513
.04% 10 2.91% .0183
.08% 17 4.94% .0074
.36% 9 2.62% .0941
.16% 3 0.87% .0089
.64% 12 3.49% .0002
3.68 .0001
.96% 11 3.20% .0045
.68% 12 3.49% .0517
.61% 95 27.62% .3187
.42% 55 15.69% .3404
able III. Result of stepwise logistic regression for main
ffects on 30-day mortality
Variable Odds ratio
95% odds ratio
confidence interval P
emale gender 3.36 1.44-7.85 .01
ge (per year) 1.08 1.02-1.15 .01
neurysm size (per cm) 1.44 1.07-1.93 .02es
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(Table VI)
Overall, 145 (5.5%) underwent emergent open surgical
repair for AAA rupture. Women comprised 34.5% of pa-
tients (n  50), men 65.5% (n  95). Women were
significantly older than men (women, 76 years vs men, 73
years; P  .04). Again at presentation, men had larger
aneurysms (men: mean AAA maximum diameter, 8.17 cm
[range, 4 cm-15 cm] vs women: mean, 6.8 cm [range, 4.5
cm-10 cm]; P .003). There were no gender differences in
the incidence of CAD (women, 38% vs men, 42.1%; P 
ns), pre-existing renal disease (women, 8.00% vs men,
8.42%; P ns), hypertension (women, 68% vs men, 64.2%;
P ns), or COPD (women, 14% vs men, 10.53%; P ns).
When compared with women, men had a significantly
higher mean EBL (men, 3230 mL vs women, 1811 mL;
P .013) but there were no differences in the mean length
of stay and any postoperative complications.
DISCUSSION
In this article, we reviewed our single center experience
in treating abdominal aortic aneurysms over a 7-year pe-
riod. We expected that our adoption of EVAR would lead
to a reduction in mortality and morbidity for our patients.
It has improved outcomes compared with historical con-
trols in our center11 and led to aneurysm surgery being
offered to greater numbers of higher-risk patients. We
expected that females would benefit as much as males from
improved outcomes. This has clearly not been the case.
Table IV. Emergent EVAR males vs females
Mal
n
Total EVAR (emergent) 73
Age (years) 72.5
Aneurysm size 6.4 (range
Factors
Coronary artery disease 48
Renal 10
Hypertension 64
Chronic obstructive pulmonary disease 17
Intraop complications
Estimated blood loss (mL) 310
Arterial rupture 3
Palmaz stent placement 10
Morbidity
Cardiac 4
Pulmonary 4
Bleeding 5
Renal 1
Colon ischemia 7
Distal ischemia 1
Length of stay (days) 8.42
30-day mortality 14
Stent graft occlusion 2
Endoleaks 22
Secondary interventions (EVAR) 22
EVAR, Endovascular aneurysm repair.This is in keeping with other large studies, most notably the s009 American College of Surgeons National Surgical
uality Improvement Program (ACS NSQIP) Study.12 In
his study, outcomes for 3662 EVAR patients over a 2-year
eriod were reviewed. As in our series, women had signifi-
antly higher mortality (3.4% vs 2.1%; P  .01) and mor-
idity (17.8% vs 10.6%; P  .001). Regression analysis
onfirms gender adversely predicted survival. In this series,
omen were 3.4 times more likely to die following EVAR
han men. There was also a higher incidence of COPD,
ntraoperative blood loss, and longer length of stay. The
xact reasons for these poorer outcomes, however, were
nclear. There are, however, several findings in our study
hat warrant consideration and may provide a partial expla-
ation. These relate to risk factor profile access, aortic neck
nd iliac artery complications, and colon ischemia.
When comparing mortality rates, any differences in risk
actors must be addressed. In this series, women and men
ndergoing elective EVAR were of similar age at time of
urgery (75 years vs 73.3 years). Women were more likely
o have COPD. This is a new finding. However, we have
lso shown that COPD is not an independent risk factor for
ortality in patients undergoing elective aneurysm re-
air.13 However, women made up a larger proportion of
uptured aneurysm patients than elective patients (33% vs
3%). This supports the notion that there is a lower index of
uspicion for AAAs in women. Alternatively, it may suggest
hat women are less likely to undergo imaging that might
erendipitously reveal an aortic aneurysm.
Access-related ischemia was a noticeable feature in our
Females
P valueotal n % of total
33 100%
74.4 .4212
m-10 cm) 6.36 (range, 4 cm-10 cm) .9065
75% 19 57.58% .6738
70% 3 9.09% .7504
67% 28 84.85% .7595
29% 5 15.15% .4415
430 .3241
11% 0 0% .5505
89% 6 1.73% .2323
48% 4 12.12% .2519
48% 3 9.09% .6746
85% 2 6.06% 1
37% 1 3.03% .5278
59% 1 3.03% .4302
37% 1 3.03% .5278
4.39 .0674
18% 9 27.27% .4457
74% 0 0% 1
14% 7 21.21% .3574
12% 3 9.09% .0248es
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Volume 55, Number 4 Mehta et al 911higher incidence of acute limb ischemia than women un-
dergoing elective open surgery. This is likely, in part, due to
smaller diameter femoral arteries in women. Wolf and
colleagues14 from Stanford also noted this in 2002. They
reported that women had significantly more intraoperative
complications. These were primarily related to arterial ac-
cess as women required arterial reconstruction more often
than men (42% vs 21%; P .05). They suggested, albeit in
relatively small numbers (n  26), that this did not corre-
late with increased mortality. Others would disagree. A
2011 review from the United Kingdom showed that all
cause survival in patients undergoing femoral artery recon-
struction was significantly poorer than those undergoing
direct closure (P  .01).15 In our series, the majority of
patients developed acute leg ischemia due to local injury to
the common femoral artery. Aminority developed ischemia
due to graft limb occlusion. There were no deaths or
amputations in this group supporting the earlier observa-
tion of Wolf.14
It was a concern to us, when we reviewed our out-
comes, that women had such a high incidence of arterial
rupture when undergoing elective EVAR compared with
men (4% vs 1.2%). As might be predicted, arterial rupture,
especially aortic neck rupture, predicted poor outcome. Of
the 14 female patients sustaining native arterial rupture, six
died. Two of the three patients with aortic neck rupture
died. We reviewed possible reasons for rupture. These
patients had very “hostile” necks for stent deployment.
While open repair may have avoided this, these patients
Table V. Elective open AAA males vs females
M
n
Total open AAA (elective) 579
Age (years) 70
Aneurysm size 6.19
Factors
Coronary artery disease 249
Renal 41
Hypertension 395
Chronic obstructive pulmonary disease 73
Intraop complications
Estimated blood loss (mL) 1394
Arterial rupture NA
Palmaz stent placement NA
Morbidity
Cardiac 12
Pulmonary 23
Bleeding 18
Renal 13
Colon ischemia 18
Distal ischemia 10
Length of stay (days) 9.13
30-day mortality 27
Stent graft occlusion NA
Endoleaks NA
Secondary interventions (EVAR) NA
AAA, Abdominal aortic aneurysm; EVAR, endovascular aneurysm repair.were also regarded as high-risk for open surgery. While hhere are few, if any, other reports detailing the conse-
uences of aortic neck rupture in higher risk EVAR pa-
ients, iliac artery rupture during endovascular aneurysm
epair is a recognized risk. In 2009, Fernandez and col-
eagues16 reported 18 ruptured iliac arteries in 17 patients.
s in our series, most were dealt with endovascularly and
ost were in women (n 13). It also correlated with greater
procedure-related mortality.” Based on our data, we agree
ith the authors that there should be a low threshold for
sing an iliac conduit in women. This problem is also being
ddressed by manufacturers who recognize the need for
ore flexible and lower profile stents to navigate difficult
liac anatomy.17
We have also reported18 previously that, in our popu-
ation, if elective EVAR patients require urgent “second-
ry” procedures for type I endoleaks and stent graft migra-
ion or limb thrombosis, mortality rises (6.0% vs 0.5%; P
05). In this series, we needed to use Palmaz stents twice as
ften in females (16% vs 8%) to “bail out” an EVAR due to
he presence of a type 1 endoleak. However, mean aneu-
ysm diameter at presentation was almost identical (men,
.63 cm vs women, 5.5 cm). This would suggest that women
ave more challenging neck anatomy than men. This alone,
ould account for much of the excess mortality in females.
Colon ischemia during aneurysm repair is a harbinger
or a poor outcome. Historically, its incidence was low after
pen elective AAA repair but more frequent after open
epair for rupture due to hypotension. Early reports from
eith’s group19 showed that EVARwas not protective, and
Females
P value% of total N % of total
100% 209 100% —
73 .0001
ge, 4 cm-16 cm) 5.79 (range, 4 cm-11 cm) .0005
43.01% 94 44.98% .6263
7.08% 18 8.61% .448
68.22% 160 76.56% .0269
12.61% 53 25.36% .0001
1157 .0074
NA
NA
2.07% 9 4.31% .1286
3.97% 13 6.22% .1810
3.11% 5 2.39% .8109
2.25% 5 2.39% 1
3.11% 9 4.31% .385
1.73% 4 1.91% .7679
12.12 .0788
4.66% 12 5.74% .5771
NA
NA
NAales
(rane proposed that microembolization during EVAR was the
u
t
b
m
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April 2012912 Mehta et alprimary reason. More recent reports suggested that newer
devices mitigated the risk.20 It is difficult, therefore, to
reconcile the increased incidence of colon ischemia in fe-
males undergoing elective EVAR, until one looks at the
absolute numbers. In fact, only three out of 344 (0.9%)
women required surgery for an ischemic colon after elective
EVAR. This compares with nine out of 209 (4.3%) requir-
ing colectomy after elective open repair. One might argue
that EVAR, far from being a risk factor for colon ischemia in
females, is actually protective when compared with open
surgery. Interestingly, this was also the finding of Becque-
min’s group21 from the University of Paris who reported in
2008 that EVAR patients had a significantly lower rate of
colon ischemia than open repair patients (4% vs 1.4%; P 
.01). This was also confirmed by others.22
There are, of course, limitations to any study. This is a
single-center series. The operations were all performed by a
small group of surgeons. This was also a retrospective
analysis of a database, with all the attendant flaws. Some
variables, such as estimated blood loss, will be good approx-
imations rather than precise measurements. However, we
are also a referral center. There may be an element of
referral bias in that we see only the more difficult patients.
This is especially true with the dissemination of endovascu-
lar technology among our referring hospitals. Although
documentation of operative complications and short-term
follow-up was performed prospectively and can be regarded
as a complete data set, as many of our patients were referred
form outside surgeons and hospitals, long-term follow-up
Table VI. Emergent open AAA males vs females
Male
n
Total open AAA (emergent) 95
Age (years) 73
Aneurysm size 8.17 (rang
Factors
Coronary artery disease 40
Renal 8
Hypertension 61
Chronic obstructive pulmonary disease 10
Intraop complications
Estimated blood loss (mL) 3230
Arterial rupture NA
Palmaz stent placement NA
Morbidity
Cardiac 1
Pulmonary 6
Bleeding 3
Renal 6
Colon ischemia 12
Distal ischemia 2
Length of stay (days) 10.4
30-day mortality 41
Stent graft occlusion NA
Endoleaks NA
Secondary interventions (EVAR) NA
AAA, Abdominal aortic aneurysm; EVAR, endovascular aneurysm repair.is incomplete. Many patients were lost to long-term follow-p. Therefore, we cannot comment in this series on long-
erm complications such as endoleaks.
Although it is disappointing that women have not
enefited as much from EVAR as men, it is still an improve-
ent over open repair. In this study, we have tried to
uantify that lack of benefit and also look at why this may be
he case. We have identified several factors, which, we
elieve, point to possible explanations for poorer outcomes
mong women. With closer attention to iliac artery anat-
my combined with the development of lower profile de-
ivery devices, we hope to reduce many of these complica-
ions. However, we still believe that EVAR remains the
reatment of choice for female patients.
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